Stacy Paggi
Child & Adolescent Psychiatry · Fairfax, VANPI 1669502993
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 288 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$600
- Supernus Pharmaceuticals, Inc.$490
- Otsuka America Pharmaceutical, Inc.$468
- Ironshore Pharmaceuticals Inc.$458
- Lundbeck LLC$390
- Sunovion Pharmaceuticals Inc.$354
- plus $3K from 21 others
What the payments were for
- Food & beverage$5,55199%
- Education$571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 30 | $600 |
| Supernus Pharmaceuticals, Inc. | 23 | $490 |
| Otsuka America Pharmaceutical, Inc. | 26 | $468 |
| Ironshore Pharmaceuticals Inc. | 24 | $458 |
| Lundbeck LLC | 19 | $390 |
| Sunovion Pharmaceuticals Inc. | 18 | $354 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $333 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $324 |
| AbbVie(2 entities) | 13 | $267 |
| Corium, LLC | 12 | $235 |
| Shire North American Group Inc | 18 | $228 |
| Tris Pharma Inc | 12 | $225 |
| Bausch Health US, LLC | 9 | $188 |
| Alkermes, Inc. | 9 | $171 |
| Axsome Therapeutics, Inc. | 9 | $170 |
| Vanda Pharmaceuticals Inc. | 5 | $167 |
| Teva Pharmaceuticals USA, Inc. | 7 | $145 |
| E.r. Squibb & Sons, L.L.C. | 4 | $82 |
| Neos Therapeutics, LP | 4 | $78 |
| Collegium Pharmaceutical, Inc. | 3 | $68 |
| Neurocrine Biosciences, Inc. | 3 | $62 |
| Noven Pharmaceuticals, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $19 |
| TMS Neurohealth Centers Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $11 |
How this compares
$5,609 in reported general payments places this provider in the 90th percentile of 115 child & adolescent psychiatry providers in Virginia.
See all child & adolescent psychiatry providers in Virginia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $873 |
| Ziprasidone Hcl | 11 | $453 |
| Lamotrigine | 12 | $236 |
| Clonazepam | 17 | $57 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Fairfax
- Vikas MangewalaFairfax$7K
- Peter RobbinsFairfax$2K
- Swapna DevFairfax$509
- Philip SmithFairfax$333
- Charles HallRichmond$10K
- Chandramouleswar AmaraPetersburg$10K
- David GouldRichmond$9K
- Rakesh ShahHopewell$7K
- Maria Carmen Rita Gonzales VigilarAshburn$6K
- Craig SwaineyRichmond$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.